Immunotherapies are promising blood cancer treatments, but they do not work for every patient. To develop enhanced therapeutics, researchers utilize sophisticated single cell techniques to understand patients actions to existing therapies and discover brand-new drug targets by tracking gene expression and profiling the immune response in heterogenous cell populations.
Download this article from 10x Genomics to discover how single cell analyses makes it possible for drug discovery and advancement in hematological oncology.
